Cynaropicrin is dual regulator for both degradation factors and synthesis factors in the cartilage metabolism

详细信息    查看全文

• 作者：Teruaki Masutani^a ; ^b ; Yuka Tsuda Tanaka^b ; Hiroyuki Kojima^b ; Makoto Tsuboi^b ; Akira Hara^c ; Masayuki Niwa^a ; ^d ; ^{mniwa@gifu-u.ac.jp" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Osteoarthritis ; NF-κB ; Cynaropicrin ; HIF-2α ; Sox9
• 刊名：Life Sciences
• 出版年：2016
• 出版时间：1 August 2016
• 年：2016
• 卷：158
• 期：Complete
• 页码：70-77
• 全文大小：894 K

文摘

The molecular mechanism of osteoarthritis (OA) has never been understood clearly, but it has been suggested that imbalance of degradation and synthesis in cartilage contribute to the underlying mechanisms of OA. In this study, we investigated the effectiveness in the cartilage metabolism of the artichoke extract that includes the compound cynaropicrin.

Main methods

We evaluated the efficacy of the artichoke extract or cynaropicrin in the cartilage metabolism factors and NF-κB signaling activity stimulated by inflammatory cytokine in chondrogenic cell lines, OUMS-27 and SW1353, using qRT-PCR, immunofluorescence and immunoblotting.

Key findings

We initially found that an artichoke extract and cynaropicrin both inhibited the increase of cartilage degradation factor MMP13 and further decreased the synthesis factor aggrecan induced by TNF-α in OUMS-27. In addition, cynaropicrin suppressed the enhancement of master regulator HIF-2α on cartilage degradation and further reduced the master regulator Sox9 on cartilage synthesis induced by TNF-α. We observed that cynaropicrin suppresses NF-κB signaling, which controls HIF-2α and Sox9. Since, HIF-2α is induced by p65 (RelA), we evaluated the effect of cynaropicrin and observed that it suppressed the nuclear transport of p65 (RelA) by inhibiting phosphorylation of IκBα. Moreover, cynaropicrin not only suppressed TNF-α stimulation, it had a similar effect on IL-1β stimulation. No significant cytotoxicity with cynaropicrin was observed.

Significance

These finding suggest that cynaropicrin is an effective substance that can improve the balance of cartilage metabolism, by altering the equilibrium of cartilage degradation and synthesis induced by multiple mediators know to contribute to OA.